Author:
Lin Tiezhu,Shi Cheng,Wu Bing,Pazo Emmanuel Eric,Shen Lijun
Abstract
Abstract
Background
To investigate the diagnostic sensitivity of Optos imaging for vision degrading myodesopsia (VDM).
Methods
A total of 420 eyes from 345 patients with VDM were collected in this cross-sectional study. All eyes were classified as having posterior vitreous detachment (PVD) or not having PVD. The sensitivity of Optos imaging for the visibility of vitreous floaters was evaluated. The associated factors with the visibility of vitreous floaters on Optos images were analyzed in univariate and multivariate logistic regression analyses.
Results
The mean age of all patients was 56.19 ± 13.89 years old, and 66.67% of patients were female. The vitreous floaters were visible on the ultrasound B scan in all eyes, but only in 47.62% of Optos images (55.29% in eyes with PVD and 15% in eyes without PVD). In the multiple binary logistic regression analysis, age (OR = 1.094, 95%CI = 1.063–1.125, P < 0.001), spherical equivalent (OR = 0.869, 95%CI = 0.791–0.955, P = 0.004) and the distance of the floaters from the retina (OR = 1.191, 95%CI = 1.059–1.339, P = 0.003) were significantly correlated with the visibility of vitreous floaters on Optos images. On Optos images, 25.71% of VDM eyes presented additional retinal abnormalities.
Conclusions
Optos imaging has a low sensitivity for vitreous floaters, particularly in eyes without PVD. On Optos imaging, floaters were more visible in older patients, eyes with greater myopia, and floaters that were further from the retina.
Funder
Shenyang Young and Middle-aged Science and Technology Innovation Talent Support Program
Publisher
Springer Science and Business Media LLC
Subject
Ophthalmology,General Medicine
Reference26 articles.
1. Webb BF, Webb JR, Schroeder MC, North CS. Prevalence of vitreous floaters in a community sample of smartphone users. Int J Ophthalmol. 2013;6:402–5.
2. Milston R, Madigan MC, Sebag J. Vitreous floaters: etiology, diagnostics, and management. Surv Ophthalmol. 2016;61:211–27.
3. Broadhead GK, Hong T, Chang AA. To treat or not to treat: Management options for symptomatic vitreous floaters. Asia Pac J Ophthalmol (Phila). 2020;9:96–103.
4. Mamou J, Wa CA, Yee KM, Silverman RH, Ketterling JA, Sadun AA, Sebag J. Ultrasound-based quantification of vitreous floaters correlates with contrast sensitivity and quality of life. Invest Ophthalmol Vis Sci. 2015;56:1611–7.
5. Sebag J. Vitreous and Vision Degrading Myodesopsia. Prog Retin Eye Res. 2020;79:100847.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献